RedHill Biopharma (RDHL) Non Operating Investment Income (2015 - 2017)
RedHill Biopharma's (RDHL) quarterly Non Operating Investment Income came in at $1.7 million in Q3 2017, up 188.03% year-over-year from $585000.0 in Q3 2016, and up 188.03% quarter-over-quarter from $585000.0 in Q3 2016.
Powered by 
Analysis
RedHill Biopharma (RDHL) Non Operating Investment Income (2015 - 2017) Analysis & Trends
RedHill Biopharma (RDHL) has reported Non Operating Investment Income for 3 consecutive years, with $1.7 million the latest figure, recorded in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 1.69 Mn |
| Sep 30, 2016 | 585,000.00 |
| Jun 30, 2016 | -514,000.00 |
| Sep 30, 2015 | -1.34 Mn |
| Jun 30, 2015 | 869,000.00 |